257 related articles for article (PubMed ID: 7533857)
21. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
22. MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.
Gregers TF; Fleckenstein B; Vartdal F; Roepstorff P; Bakke O; Sandlie I
Int Immunol; 2003 Nov; 15(11):1291-9. PubMed ID: 14565927
[TBL] [Abstract][Full Text] [Related]
23. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
Carstens C; Newman DK; Bohlen H; König A; Koch N
Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
[TBL] [Abstract][Full Text] [Related]
24. Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector.
Hofer T; Tangkeangsirisin W; Kennedy MG; Mage RG; Raiker SJ; Venkatesh K; Lee H; Giger RJ; Rader C
J Immunol Methods; 2007 Jan; 318(1-2):75-87. PubMed ID: 17140598
[TBL] [Abstract][Full Text] [Related]
25. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
[TBL] [Abstract][Full Text] [Related]
26. Epitope mapping, V-region DNA sequence, and neutralizing Fab fragments of two monoclonal antibodies against the HIV-1 V3 loop.
Duarte CA; Pérez L; Vázquez J; Dueñas M; Vilarrubia OL; Navea L; Valdés R; Reyes O; Montero M; Ayala M; Gavilondo J
Immunotechnology; 1996 Feb; 2(1):11-20. PubMed ID: 9373324
[TBL] [Abstract][Full Text] [Related]
27. Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments.
Gilliland LK; Norris NA; Marquardt H; Tsu TT; Hayden MS; Neubauer MG; Yelton DE; Mittler RS; Ledbetter JA
Tissue Antigens; 1996 Jan; 47(1):1-20. PubMed ID: 8929708
[TBL] [Abstract][Full Text] [Related]
28. Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptides.
Moro M; Cecconi V; Martinoli C; Dallegno E; Giabbai B; Degano M; Glaichenhaus N; Protti MP; Dellabona P; Casorati G
BMC Immunol; 2005 Dec; 6():24. PubMed ID: 16329759
[TBL] [Abstract][Full Text] [Related]
29. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.
Chames P; Hufton SE; Coulie PG; Uchanska-Ziegler B; Hoogenboom HR
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7969-74. PubMed ID: 10884427
[TBL] [Abstract][Full Text] [Related]
30. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a single-chain antibody to the beta-chain of the T cell receptor.
Cho BK; Schodin BA; Kranz DM
J Biol Chem; 1995 Oct; 270(43):25819-26. PubMed ID: 7592766
[TBL] [Abstract][Full Text] [Related]
32. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
Wagner R; Böltz T; Deml L; Modrow S; Wolf H
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1261-9. PubMed ID: 7687647
[TBL] [Abstract][Full Text] [Related]
33. Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms.
Fujita H; Senju S; Yokomizo H; Saya H; Ogawa M; Matsushita S; Nishimura Y
Eur J Immunol; 1998 Jan; 28(1):305-16. PubMed ID: 9485210
[TBL] [Abstract][Full Text] [Related]
34. Human recombinant antibody fragments specific for a rye-grass pollen allergen: characterization and potential applications.
de Lalla C; Tamborini E; Longhi R; Tresoldi E; Manoni M; Siccardi AG; Arosio P; Sidoli A
Mol Immunol; 1996 Sep; 33(13):1049-58. PubMed ID: 9010244
[TBL] [Abstract][Full Text] [Related]
35. Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody.
Chen SY; Khouri Y; Bagley J; Marasco WA
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5932-6. PubMed ID: 8016092
[TBL] [Abstract][Full Text] [Related]
36. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
Pawelec G; Schneider EM; Müller C; Wernet P
Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
[TBL] [Abstract][Full Text] [Related]
37. Direct mapping of MHC class II epitopes.
Milosevic S; Behrends U; Christoph H; Mautner J
J Immunol Methods; 2005 Nov; 306(1-2):28-39. PubMed ID: 16168435
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.
Becker Y
Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271
[TBL] [Abstract][Full Text] [Related]
39. A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.
Rajnavölgyi E; Nagy N; Thuresson B; Dosztányi Z; Simon A; Simon I; Karr RW; Ernberg I; Klein E; Falk KI
Int Immunol; 2000 Mar; 12(3):281-93. PubMed ID: 10700463
[TBL] [Abstract][Full Text] [Related]
40. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR
J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
